-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Upgrades Neogen to Overweight, Raises Price Target to $14

Benzinga·08/26/2026 16:45:20
Listen to the news
Piper Sandler analyst David Westenberg upgrades Neogen (NASDAQ:NEOG) from Neutral to Overweight and raises the price target from $13 to $14.